Deerfield Mgmt, L.P. 13D and 13G filings for Cullinan Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-13 4:28 pm Sale | 2025-09-30 | 13G | Cullinan Therapeutics, Inc. CGEM | Deerfield Mgmt, L.P. | 2,927,013 4.950% | -356,811 (-10.87%) | Filing |
| 2024-04-24 5:50 pm Purchase | 2024-04-18 | 13G | Cullinan Therapeutics, Inc. CGEM | Deerfield Mgmt, L.P. | 3,283,824 5.710% | 3,283,824 (New Position) | Filing |